SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 144 - Report of proposed sale of securities:
SEC Accession No. 0000048966-24-000013
Filing Date
2024-05-16
Accepted
2024-05-16 17:12:49
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 144  
1 primary_doc.xml 144 4027
  Complete submission text file 0000048966-24-000013.txt   5963
Mailing Address 1 LIBERTY LANE E SUITE 112 HAMPTON NH 03842
Business Address 1 LIBERTY LANE E SUITE 112 HAMPTON NH 03842 603.339.0084
Novalis LifeSciences Investments I, L.P. (Reporting) CIK: 0001781605 (see all company filings)

IRS No.: 842004275 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 144

Mailing Address 27 DRYDOCK AVENUE 8TH FLOOR BOSTON MA 02210
Business Address 27 DRYDOCK AVENUE 8TH FLOOR BOSTON MA 02210 (877) 442-5362
Ginkgo Bioworks Holdings, Inc. (Subject) CIK: 0001830214 (see all company filings)

IRS No.: 872652913 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 144 | Act: 33 | File No.: 001-40097 | Film No.: 24956704
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)